| Financial Year |
March 31 2023 |
| Monetary Funds |
778,614,548.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,439,906.89 |
| Accounts Receivable |
964,173,070.58 |
| Advances to Suppliers |
280,818,779.61 |
| Other Receivables |
199,794,715.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
757,373,693.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
40,359,253.25 |
| Other Current Assets |
155,217,819.58 |
| Total Current Assets |
3,307,674,195.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
270,889,918.95 |
| Investment Properties |
518,285,328.05 |
| Fixed Assetes |
4,202,065,657.11 |
| Under-construction Projects |
1,164,663,651.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,228,903,459.39 |
| R&D expenses |
2,438,861.60 |
| Goodwill |
985,053,444.89 |
| Long-Term Deferred and Prepaid Expenses |
96,381,663.48 |
| Deferred Income Tax Assets |
25,772,241.53 |
| Other Non-Current Assets |
143,688,065.53 |
| Sub-Total of Non-Current Assets |
8,656,028,702.05 |
| Total Assets |
11,963,702,897.68 |
| Short-Term Loans |
856,078,259.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
565,237,638.59 |
| Accounts Received In Advance |
1,613,961.25 |
| Employee Compensation Payable |
21,113,551.86 |
| Taxes Payable |
26,432,940.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
471,688,748.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
631,675,944.42 |
| Other Current Liabilities |
507,637,638.04 |
| Sub-Total of Current Liabilities |
3,354,974,668.04 |
| Long-term Loans |
3,082,165,797.62 |
| Bonds Payable |
499,888,505.12 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
176,430,040.24 |
| Deferred Income Tax Liabilities |
32,735,319.15 |
| Other Non-Current Liabilities |
4,726,667.67 |
| Sub-Total of Non-Current Liabilities |
3,979,346,809.19 |
| Total Liabilities |
7,334,321,477.23 |
| Paid-In Capital(Or Share Stock) |
879,267,102.40 |
| Capital Surplus |
451,166,208.23 |
| Surplus Reserve |
269,816,271.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,319,006,846.28 |
| Minority Stockholder's Interest |
690,520,855.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,938,860,565.43 |
| Owner's Equity（Stockholder's Equity） |
4,629,381,420.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,963,702,897.68 |
